help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, T. A.
Right arrow Articles by Horwitz, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, T. A.
Right arrow Articles by Horwitz, K. B.
Molecular Endocrinology 11 (6): 693-705
Copyright © 1997 by The Endocrine Society

The Partial Agonist Activity of Antagonist-Occupied Steroid Receptors Is Controlled by a Novel Hinge Domain-Binding Coactivator L7/SPA and the Corepressors N-CoR or SMRT

Twila A. Jackson, Jennifer K. Richer, David L. Bain, Glenn S. Takimoto, Lin Tung and Kathryn B. Horwitz

Departments of Medicine and Pathology and the Molecular, Biology Program, University of Colorado Health Sciences Center, Denver, Colorado 80262

Steroid receptor antagonists, such as the antiestrogen tamoxifen or the antiprogestin RU486, can have inappropriate agonist-like effects in tissues and tumors. To explain this paradox we postulated that coactivators are inadvertently brought to the promoters of DNA-bound, antagonist-occupied receptors. The human (h) progesterone receptor (PR) hinge-hormone binding domain (H-HBD) was used as bait in a two-hybrid screen of a HeLa cDNA library, in which the yeast cells were treated with RU486. We have isolated and characterized two interesting steroid receptor-interacting proteins that regulate transcription in opposite directions. The first is L7/SPA, a previously described 27-kDa protein containing a basic region leucine zipper domain, having no known nuclear function. When coexpressed with tamoxifen-occupied estrogen receptors (hER) or RU486-occupied hPR or glucocorticoid receptors (hGR), L7/SPA increases the partial agonist activity of the antagonists by 3- to 10-fold, but it has no effect on agonist-mediated transcription. The interaction of L7/SPA with hPR maps to the hinge region, and indeed, the hPR hinge region squelches L7/SPA-dependent induction of antagonist-mediated transcription. Interestingly, pure antagonists that lack partial agonist effects, such as the antiestrogen ICI164,384 or the antiprogestin ZK98299, cannot be up-regulated by L7/SPA. We also isolated, cloned, and sequenced the human homolog (hN-CoR) of the 270-kDa mouse (m) thyroid/retinoic acid receptor corepressor. Binding of hN-CoR maps to the hPR-HBD. mN-CoR, and a related human corepressor, SMRT, suppress RU486 or tamoxifen-mediated partial agonist activity by more than 90%. This suppression is completely squelched by overexpression of the hPR H-HBD. Additionally, both corepressors reverse the antagonist-dependent transcriptional up-regulation produced by L7/SPA. Our data suggest that the direction of transcription by antagonist-occupied steroid receptors can be controlled by the ratio of coactivators to corepressors recruited to the transcription complex by promoter-bound receptors. In normal tissues and in hormone-resistant breast cancers in which the agonist activity of mixed antagonists predominates, steroid receptors may be preferentially bound by coactivators. This suggests a strategy by which such partial agonist activity can be eliminated and by which candidate receptor ligands can be screened for this activity.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
M. H. Liu, J. Li, P. Shen, B. Husna, E. S. Tai, and E. L. Yong
A Natural Polymorphism in Peroxisome Proliferator-Activated Receptor-{alpha} Hinge Region Attenuates Transcription due to Defective Release of Nuclear Receptor Corepressor from Chromatin
Mol. Endocrinol., May 1, 2008; 22(5): 1078 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Cheng, C. Zhang, and D. J. Shapiro
A Functional Serine 118 Phosphorylation Site in Estrogen Receptor-{alpha} Is Required for Down-Regulation of Gene Expression by 17{beta}-Estradiol and 4-Hydroxytamoxifen
Endocrinology, October 1, 2007; 148(10): 4634 - 4641.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Kressler, M. B. Hock, and A. Kralli
Coactivators PGC-1beta and SRC-1 Interact Functionally to Promote the Agonist Activity of the Selective Estrogen Receptor Modulator Tamoxifen
J. Biol. Chem., September 14, 2007; 282(37): 26897 - 26907.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. J. Peterson, S. Karmakar, M. C. Pace, T. Gao, and C. L. Smith
The Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor (SMRT) Corepressor Is Required for Full Estrogen Receptor {alpha} Transcriptional Activity
Mol. Cell. Biol., September 1, 2007; 27(17): 5933 - 5948.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al.
Estrogen Receptors: How Do They Signal and What Are Their Targets
Physiol Rev, July 1, 2007; 87(3): 905 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Lupien, M. Jeyakumar, E. Hebert, K. Hilmi, D. Cotnoir-White, C. Loch, A. Auger, G. Dayan, G.-A. Pinard, J.-M. Wurtz, et al.
Raloxifene and ICI182,780 Increase Estrogen Receptor-{alpha} Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12
Mol. Endocrinol., April 1, 2007; 21(4): 797 - 816.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
A. Romano, B. Delvoux, D.-C. Fischer, and P. Groothuis
The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone
J. Mol. Endocrinol., February 1, 2007; 38(2): 331 - 350.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
E. B. Dammer, A. Leon, and M. B. Sewer
Coregulator Exchange and Sphingosine-Sensitive Cooperativity of Steroidogenic Factor-1, General Control Nonderepressed 5, p54, and p160 Coactivators Regulate Cyclic Adenosine 3',5'-Monophosphate-Dependent Cytochrome P450c17 Transcription Rate
Mol. Endocrinol., February 1, 2007; 21(2): 415 - 438.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. Lopez-Garcia, M. Periyasamy, R. S. Thomas, M. Christian, M. Leao, P. Jat, K. B. Kindle, D. M. Heery, M. G. Parker, L. Buluwela, et al.
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases
Nucleic Acids Res., December 4, 2006; 34(21): 6126 - 6136.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet
Overview of Nomenclature of Nuclear Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 685 - 704.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
L. Michalik, J. Auwerx, J. P. Berger, V. K. Chatterjee, C. K. Glass, F. J. Gonzalez, P. A. Grimaldi, T. Kadowaki, M. A. Lazar, S. O'Rahilly, et al.
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 726 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al.
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797.
[Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Y. Wu, H. Kawate, K. Ohnaka, H. Nawata, and R. Takayanagi
Nuclear Compartmentalization of N-CoR and Its Interactions with Steroid Receptors.
Mol. Cell. Biol., September 1, 2006; 26(17): 6633 - 6655.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Cui, A. Niu, R. Pestell, R. Kumar, E. M. Curran, Y. Liu, and S. A. W. Fuqua
Metastasis-Associated Protein 2 Is a Repressor of Estrogen Receptor {alpha} Whose Overexpression Leads to Estrogen-Independent Growth of Human Breast Cancer Cells
Mol. Endocrinol., September 1, 2006; 20(9): 2020 - 2035.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Georgiakaki, N. Chabbert-Buffet, B. Dasen, G. Meduri, S. Wenk, L. Rajhi, L. Amazit, A. Chauchereau, C. W. Burger, L. J. Blok, et al.
Ligand-Controlled Interaction of Histone Acetyltransferase Binding to ORC-1 (HBO1) with the N-Terminal Transactivating Domain of Progesterone Receptor Induces Steroid Receptor Coactivator 1-Dependent Coactivation of Transcription
Mol. Endocrinol., September 1, 2006; 20(9): 2122 - 2140.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Carascossa, J. Gobinet, V. Georget, A. Lucas, E. Badia, A. Castet, R. White, J.-C. Nicolas, V. Cavailles, and S. Jalaguier
Receptor-Interacting Protein 140 Is a Repressor of the Androgen Receptor Activity
Mol. Endocrinol., July 1, 2006; 20(7): 1506 - 1518.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely
Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity
Mol. Endocrinol., June 1, 2006; 20(6): 1322 - 1332.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Cuzzocrea, E. Mazzon, R. Di Paola, A. Peli, A. Bonato, D. Britti, T. Genovese, C. Muia, C. Crisafulli, and A. P. Caputi
The role of the peroxisome proliferator-activated receptor-{alpha} (PPAR-{alpha}) in the regulation of acute inflammation
J. Leukoc. Biol., May 1, 2006; 79(5): 999 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Chadli, J. D. Graham, M. G. Abel, T. A. Jackson, D. F. Gordon, W. M. Wood, S. J. Felts, K. B. Horwitz, and D. Toft
GCUNC-45 Is a Novel Regulator for the Progesterone Receptor/hsp90 Chaperoning Pathway.
Mol. Cell. Biol., March 1, 2006; 26(5): 1722 - 1730.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. H. Baek, K. A. Ohgi, C. A. Nelson, D. Welsbie, C. Chen, C. L. Sawyers, D. W. Rose, and M. G. Rosenfeld
Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells
PNAS, February 28, 2006; 103(9): 3100 - 3105.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. P. Gray, J. W. Davis II, L. Gopinathan, T. L. Leas, C. A. Nugent, and J. P. Vanden Heuvel
The Ribosomal Protein rpL11 Associates with and Inhibits the Transcriptional Activity of Peroxisome Proliferator-Activated Receptor-{alpha}
Toxicol. Sci., February 1, 2006; 89(2): 535 - 546.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. R Gunthert, C. Grundker, A. Olota, J. Lasche, N. Eicke, and G. Emons
Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen
Eur. J. Endocrinol., October 1, 2005; 153(4): 613 - 625.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. J. Han, J. Jeong, F. J. DeMayo, J. Xu, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley
Dynamic Cell Type Specificity of SRC-1 Coactivator in Modulating Uterine Progesterone Receptor Function in Mice
Mol. Cell. Biol., September 15, 2005; 25(18): 8150 - 8165.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Frasor, J. M. Danes, C. C. Funk, and B. S. Katzenellenbogen
Estrogen down-regulation of the corepressor N-CoR: Mechanism and implications for estrogen derepression of N-CoR-regulated genes
PNAS, September 13, 2005; 102(37): 13153 - 13157.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
Endocr. Relat. Cancer, September 1, 2005; 12(3): 511 - 532.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Wang and S. S. Simons Jr.
Corepressor Binding to Progesterone and Glucocorticoid Receptors Involves the Activation Function-1 Domain and Is Inhibited by Molybdate
Mol. Endocrinol., June 1, 2005; 19(6): 1483 - 1500.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
E. K. Keeton and M. Brown
Cell Cycle Progression Stimulated by Tamoxifen-Bound Estrogen Receptor-{alpha} and Promoter-Specific Effects in Breast Cancer Cells Deficient in N-CoR and SMRT
Mol. Endocrinol., June 1, 2005; 19(6): 1543 - 1554.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R.-C. Wu, C. L. Smith, and B. W. O'Malley
Transcriptional Regulation by Steroid Receptor Coactivator Phosphorylation
Endocr. Rev., May 1, 2005; 26(3): 393 - 399.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger
Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
Endocr. Rev., May 1, 2005; 26(3): 423 - 438.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Myers, A. D.K. Hill, G. Kelly, E. W. McDermott, N. J. O'Higgins, Y. Buggy, and L. S. Young
Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer
Clin. Cancer Res., March 15, 2005; 11(6): 2111 - 2122.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. C. Hodgson, I. Astapova, S. Cheng, L. J. Lee, M. C. Verhoeven, E. Choi, S. P. Balk, and A. N. Hollenberg
The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists
J. Biol. Chem., February 25, 2005; 280(8): 6511 - 6519.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Jung, R.-S. Kim, H.-J. Zhang, S.-J. Lee, and M.-H. Jeng
HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling
Cancer Res., December 15, 2004; 64(24): 9185 - 9192.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. U. Agoulnik, X.-W. Tong, D.-C. Fischer, K. Korner, N. E. Atkinson, D. P. Edwards, D. R. Headon, N. L. Weigel, and D. G. Kieback
A Germline Variation in the Progesterone Receptor Gene Increases Transcriptional Activity and May Modify Ovarian Cancer Risk
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6340 - 6347.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. H. Herynk and S. A. W. Fuqua
Estrogen Receptor Mutations in Human Disease
Endocr. Rev., December 1, 2004; 25(6): 869 - 898.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C E Waters, A Stevens, A White, and D W Ray
Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line
J. Endocrinol., November 1, 2004; 183(2): 375 - 383.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Masiello, S.-Y. Chen, Y. Xu, M. C. Verhoeven, E. Choi, A. N. Hollenberg, and S. P. Balk
Recruitment of {beta}-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells
Mol. Endocrinol., October 1, 2004; 18(10): 2388 - 2401.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. K. Goff
Steroid Hormone Modulation of Prostaglandin Secretion in the Ruminant Endometrium During the Estrous Cycle
Biol Reprod, July 1, 2004; 71(1): 11 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Q. Wang, J. A. Blackford Jr., L.-N. Song, Y. Huang, S. Cho, and S. S. Simons Jr.
Equilibrium Interactions of Corepressors and Coactivators with Agonist and Antagonist Complexes of Glucocorticoid Receptors
Mol. Endocrinol., June 1, 2004; 18(6): 1376 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N. Heldring, M. Nilsson, B. Buehrer, E. Treuter, and J.-A. Gustafsson
Identification of Tamoxifen-Induced Coregulator Interaction Surfaces within the Ligand-Binding Domain of Estrogen Receptors
Mol. Cell. Biol., April 15, 2004; 24(8): 3445 - 3459.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Frasor, F. Stossi, J. M. Danes, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen
Selective Estrogen Receptor Modulators: Discrimination of Agonistic versus Antagonistic Activities by Gene Expression Profiling in Breast Cancer Cells
Cancer Res., February 15, 2004; 64(4): 1522 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Strom, J. Hartman, J. S. Foster, S. Kietz, J. Wimalasena, and J.-A. Gustafsson
Estrogen receptor {beta} inhibits 17{beta}-estradiol-stimulated proliferation of the breast cancer cell line T47D
PNAS, February 10, 2004; 101(6): 1566 - 1571.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. L. Smith and B. W. O'Malley
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Endocr. Rev., February 1, 2004; 25(1): 45 - 71.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L.-N. Song, M. Coghlan, and E. P. Gelmann
Antiandrogen Effects of Mifepristone on Coactivator and Corepressor Interactions with the Androgen Receptor
Mol. Endocrinol., January 1, 2004; 18(1): 70 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. De Bosscher, W. Vanden Berghe, and G. Haegeman
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression
Endocr. Rev., August 1, 2003; 24(4): 488 - 522.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
R.D. Catalano, A. Yanaihara, A.L. Evans, D. Rocha, A. Prentice, S. Saidi, C.G. Print, D.S. Charnock-Jones, A.M. Sharkey, and S.K. Smith
The effect of RU486 on the gene expression profile in an endometrial explant model
Mol. Hum. Reprod., August 1, 2003; 9(8): 465 - 473.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. J. Morrison, R. E. Herrera, E. C. Heinsohn, R. Schiff, and C. K. Osborne
Dominant-Negative Nuclear Receptor Corepressor Relieves Transcriptional Inhibition of Retinoic Acid Receptor but Does Not Alter the Agonist/Antagonist Activities of the Tamoxifen-Bound Estrogen Receptor
Mol. Endocrinol., August 1, 2003; 17(8): 1543 - 1554.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Stevens, H. Garside, A. Berry, C. Waters, A. White, and D. Ray
Dissociation of Steroid Receptor Coactivator 1 and Nuclear Receptor Corepressor Recruitment to the Human Glucocorticoid Receptor by Modification of the Ligand-Receptor Interface: The Role of Tyrosine 735
Mol. Endocrinol., May 1, 2003; 17(5): 845 - 859.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Wu, Y. Wu, B. Gathings, M. Wan, X. Li, W. Grizzle, Z. Liu, C. Lu, Z. Mao, and X. Cao
Smad4 as a Transcription Corepressor for Estrogen Receptor alpha
J. Biol. Chem., April 18, 2003; 278(17): 15192 - 15200.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. Farboud, H. Hauksdottir, Y. Wu, and M. L. Privalsky
Isotype-Restricted Corepressor Recruitment: a Constitutively Closed Helix 12 Conformation in Retinoic Acid Receptors {beta} and {gamma} Interferes with Corepressor Recruitment and Prevents Transcriptional Repression
Mol. Cell. Biol., April 15, 2003; 23(8): 2844 - 2858.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Girault, F. Lerebours, S. Amarir, S. Tozlu, M. Tubiana-Hulin, R. Lidereau, and I. Bieche
Expression Analysis of Estrogen Receptor {alpha} Coregulators in Breast Carcinoma: Evidence That NCOR1 Expression Is Predictive of the Response to Tamoxifen
Clin. Cancer Res., April 1, 2003; 9(4): 1259 - 1266.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. K. Osborne, V. Bardou, T. A. Hopp, G. C. Chamness, S. G. Hilsenbeck, S. A. W. Fuqua, J. Wong, D. C. Allred, G. M. Clark, and R. Schiff
Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer
J Natl Cancer Inst, March 5, 2003; 95(5): 353 - 361.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Webb, P. Nguyen, and P. J. Kushner
Differential SERM Effects on Corepressor Binding Dictate ERalpha Activity in Vivo
J. Biol. Chem., February 21, 2003; 278(9): 6912 - 6920.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Liao, L.-Y. Chen, A. Zhang, A. Godavarthy, F. Xia, J. C. Ghosh, H. Li, and J. D. Chen
Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT
J. Biol. Chem., February 7, 2003; 278(7): 5052 - 5061.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Schiff, S. Massarweh, J. Shou, and C. K. Osborne
Breast Cancer Endocrine Resistance: How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response
Clin. Cancer Res., January 1, 2003; 9(1): 447S - 454S.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. A. Leonhardt and D. P. Edwards
Mechanism of Action of Progesterone Antagonists
Experimental Biology and Medicine, December 1, 2002; 227(11): 969 - 980.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
E. Demirpence, A. Semlali, J. Oliva, P. Balaguer, E. Badia, M.-J. Duchesne, J.-C. Nicolas, and M. Pons
An Estrogen-responsive Element-targeted Histone Deacetylase Enzyme Has an Antiestrogen Activity That Differs from That of Hydroxytamoxifen
Cancer Res., November 15, 2002; 62(22): 6519 - 6528.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. N. Moraitis, V. Giguere, and C. C. Thompson
Novel Mechanism of Nuclear Receptor Corepressor Interaction Dictated by Activation Function 2 Helix Determinants
Mol. Cell. Biol., October 1, 2002; 22(19): 6831 - 6841.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
I. Dussault, M. Lin, K. Hollister, M. Fan, J. Termini, M. A. Sherman, and B. M. Forman
A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity
Mol. Cell. Biol., August 1, 2002; 22(15): 5270 - 5280.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. E. Wardell, V. Boonyaratanakornkit, J. S. Adelman, A. Aronheim, and D. P. Edwards
Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator
Mol. Cell. Biol., August 1, 2002; 22(15): 5451 - 5466.
[Abstract] [Full Text] [PDF]

Home page